Aberrant miRNA expression and protein arginine methyltransferase 5 (PRMT5) in cancer: A review

被引:0
|
作者
Sif, Said [1 ]
Al Alawneh, Majdi [1 ]
机构
[1] Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2025年 / 1872卷 / 03期
关键词
Protein arginine methyltransferase 5; WNT/beta-CATENIN signaling; PI3K/AKT signaling; Tumor suppressor miRNA; Glioblastoma; PROLIFERATION; MIGRATION; INHIBITION; INVASION; CELLS; TUMOR; GENE; AXIS;
D O I
10.1016/j.bbamcr.2025.119923
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The search for important factors involved in triggering and promoting cancer cell growth and survival has led to the identification of key players, including transcription factors, chromatin remodelers, epigenetic modifying enzymes, signaling molecules, and miRNAs. However, the interplay and crosstalk between some of these factors and the impact they have on tumorigenesis remains largely unexplored. In this review, we focus on type II protein arginine methyltransferase 5 (PRMT5)-mediated epigenetic silencing and its regulatory tumor suppressor miRNAs, as well as the mechanisms by which circular PRMT5 RNA (circ-PRMT5) promotes cancer cell proliferation and survival.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells
    Rasheed, Shayaan
    Bouley, Renee A.
    Yoder, Ryan J.
    Petreaca, Ruben C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [2] Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors
    Lin, Hong
    Luengo, Juan, I
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (11) : 1264 - 1269
  • [3] Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)
    Palte, Rachel L.
    Schneider, Sebastian E.
    Altman, Michael D.
    Hayes, Robert P.
    Kawamura, Shuhei
    Lacey, Brian M.
    Mansueto, My Sam
    Reutershan, Michael
    Siliphaivanh, Phieng
    Sondey, Christopher
    Xu, Haiyan
    Xu, Zangwei
    Ye, Yingchun
    Machacek, Michelle R.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (09): : 1688 - 1693
  • [4] Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: A review
    Feustel, Kavanya
    Falchook, Gerald S.
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2022, 5 (03) : 58 - 67
  • [5] Arginine methylation regulates IL-2 gene expression:: a role for protein arginine methyltransferase 5 (PRMT5)
    Richard, S
    Morel, M
    Cléroux, P
    BIOCHEMICAL JOURNAL, 2005, 388 : 379 - 386
  • [6] Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors
    Lin, Hong
    Wang, Min
    Zhang, Yang W.
    Tong, Shuilong
    Leal, Raul A.
    Shetty, Rupa
    Vaddi, Kris
    Luengo, Juan I.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (07): : 1033 - 1038
  • [7] Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders
    Shen, Yudao
    Gao, Guozhen
    Yu, Xufen
    Kim, Huensuk
    Wang, Li
    Xie, Ling
    Schwarz, Megan
    Chen, Xian
    Guccione, Ernesto
    Liu, Jing
    Bedford, Mark T.
    Jin, Jian
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (17) : 9977 - 9989
  • [8] Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery
    Wang, Yuanxiang
    Hu, Wenhao
    Yuan, Yanqiu
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (21) : 9429 - 9441
  • [9] Protein arginine methyltransferase 5 (PRMT5) is a novel negative regulator of keratinocyte differentiation
    Kanade, S. R.
    Eckert, R. L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S60 - S60
  • [10] Novel inhibitors of protein arginine methyltransferase 5 (PRMT5) for the treatment of solid tumors
    Chikkanna, Dinesh
    Panigrahi, Sunil Kumar
    Rajagopalan, Sujatha
    Sammeta, Srinivasa Raju
    Lakshminarasimhan, Anirudha
    Mohan, R.
    Narasihmarao, K.
    Chawla, Darshan
    Bhat, Harsha
    Kasturi, Venkateswarlu
    Samiulla, D. S.
    Prasanna, Angelene
    Aithal, Kiran
    Chand, Priyabrata Chand
    Kumar, Naveen
    Marri, Sai Sudheer
    Ganipisetty, Srinivasa Rao
    Rao, Kasieswara N.
    Mutyala, Raju
    Neerukattu, Nageswara Rao
    Nithesh, K.
    Amin, Ramya
    Gorade, Priyanka Machhindra
    Antony, Thomas
    Daginakatte, Girish
    Chelur, Shekar
    Pandit, Chetan
    Samajdar, Susanta
    Ramachandra, Murali
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)